Suppr超能文献

氨哌嗪类似物FG5865和FG5893的5-HT1A自身受体介导的对大鼠脑内5-羟色胺神经化学的体内效应。

5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.

作者信息

Hjorth S, Pettersson G

机构信息

Department of Pharmacology, University of Göteborg, Sweden.

出版信息

Eur J Pharmacol. 1993 Jul 20;238(2-3):357-67. doi: 10.1016/0014-2999(93)90867-h.

Abstract

The two diphenylbutylpiperazinepyridinyl derivatives, FG5865 and FG5893, have a unique receptor binding profile in that they show very high and essentially equipotent affinities for both 5-HT1A and 5-HT2 receptors. The present report describes the acute effects of FG5865 and FG5893 on presynaptic 5-hydroxytryptamine (5-HT) neuronal function in the rat CNS, using established ex vivo and in vivo neurochemical techniques. Post-mortem measurements of tissue levels of 5-HT, its metabolite, 5-hydroxyindoleacetic acid (5-HIAA), and of the formation of 5-hydroxytryptophan (5-HTP; after inhibition of aromatic amino acid decarboxylase by NSD 1015) showed that FG5865 (0.1-20 mg/kg, s.c.) and FG5893 (0.1-20 mg/kg, s.c.) dose dependently decreased the synthesis and the metabolism/turnover of 5-HT--this to an extent comparable to the reference 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Reserpine (5 mg/kg, s.c.) pretreatment did not prevent the FG5893-induced decrease of 5-HT synthesis rate. In contrast, about 25-50 times higher doses of FG5865 were required to produce a comparable decrease in brain 5-HT synthesis in reserpinized vs. non-pretreated rats. In in vivo microdialysis experiments, both FG5865 (0.1-3.0 mg/kg, s.c.) and FG5893 (0.03-1.0 mg/kg, s.c.) caused a marked and dose-dependent decrease of 5-HT release in the ventral hippocampus. Pretreatment with the 5-HT1A receptor antagonist, (+/-)-pindolol (8 mg/kg, s.c.), abolished the FG5865 (0.3 mg/kg, s.c.)-induced reduction of 5-HT release, and (-)-pindolol (8 mg/kg, s.c.) similarly reversed the FG5893 (0.3 mg/kg, s.c.)-induced decrease. Local infusion of FG5865 into the ventral hippocampus (10 microM, 20-min pulse) resulted in a rapid and transient elevation of the 5-HT output, an effect that was independent of extracellular Ca2+. FG5893, on the other hand, did not affect the 5-HT release upon local administration. The results demonstrate that FG5865 and FG5893 potently affect a range of neurochemical indices of rat brain 5-HT neuronal activity in vivo, in a way consistent with indirect (FG5865) and direct (FG5865 and FG5893) stimulation of the 5-HT1A autoreceptors in the raphe nuclei.

摘要

两种二苯基丁基哌嗪吡啶基衍生物FG5865和FG5893具有独特的受体结合特性,即它们对5-HT1A和5-HT2受体均表现出非常高且基本等效的亲和力。本报告使用既定的离体和体内神经化学技术,描述了FG5865和FG5893对大鼠中枢神经系统中突触前5-羟色胺(5-HT)神经元功能的急性影响。对5-HT及其代谢产物5-羟吲哚乙酸(5-HIAA)的组织水平以及5-羟色氨酸(5-HTP;在NSD 1015抑制芳香族氨基酸脱羧酶后)形成的死后测量表明,FG5865(0.1 - 20 mg/kg,皮下注射)和FG5893(0.1 - 20 mg/kg,皮下注射)剂量依赖性地降低了5-HT的合成以及代谢/周转——其程度与参考5-HT1A受体激动剂8-羟基-2-(二正丙基氨基)四氢萘相当。利血平(5 mg/kg,皮下注射)预处理并不能阻止FG5893诱导的5-HT合成速率降低。相比之下,在利血平化大鼠与未预处理大鼠中,产生相当的脑5-HT合成降低所需的FG5865剂量要高出约25 - 50倍。在体内微透析实验中,FG5865(0.1 - 3.0 mg/kg,皮下注射)和FG5893(0.03 - 1.0 mg/kg,皮下注射)均导致腹侧海马中5-HT释放显著且剂量依赖性地降低。用5-HT1A受体拮抗剂(±)-吲哚洛尔(8 mg/kg,皮下注射)预处理可消除FG5865(0.3 mg/kg,皮下注射)诱导的5-HT释放减少,而(-)-吲哚洛尔(8 mg/kg,皮下注射)同样可逆转FG5893(0.3 mg/kg,皮下注射)诱导的降低。将FG5865局部注入腹侧海马(10 μM,20分钟脉冲)导致5-HT输出快速且短暂升高,该效应与细胞外Ca2+无关。另一方面,局部给药时FG5893不影响5-HT释放。结果表明,FG5865和FG5893在体内能有效影响大鼠脑5-HT神经元活动的一系列神经化学指标,其方式与间接(FG5865)和直接(FG5865和FG5893)刺激中缝核中的5-HT1A自身受体一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验